Yuwaraj Kadariya
Overview
Explore the profile of Yuwaraj Kadariya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
541
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kadariya Y, Sementino E, Hua X, Kappes D, Testa J
Curr Protoc
. 2025 Jan;
5(1):e70086.
PMID: 39791266
Mesothelioma is a lethal cancer of the serosal lining of the body cavities. Risk factors include environmental and genetic factors. Asbestos exposure is considered the principal environmental risk factor, but...
2.
Testa J, Kadariya Y, Friedberg J
Oncoscience
. 2024 May;
11:53-57.
PMID: 38784478
Mesothelioma is an incurable cancer of the mesothelial lining often caused by exposure to asbestos. Asbestos-induced inflammation is a significant contributing factor in the development of mesothelioma, and genetic factors...
3.
Kadariya Y, Sementino E, Ruan M, Cheung M, Hadikhani P, Osmanbeyoglu H, et al.
Cancer Res Commun
. 2024 Apr;
4(4):1004-1015.
PMID: 38592450
Significance: We show that germline Bap1-mutant mice have enhanced susceptibility to MM upon minimal exposure to chrysotile asbestos, not only amphibole fibers. Chrysotile induced a more profound immune tumor response...
4.
Kadariya Y, Sementino E, Shrestha U, Gorman G, White J, Ross E, et al.
Carcinogenesis
. 2022 Nov;
43(12):1137-1148.
PMID: 36355620
Malignant mesothelioma (MM) is an incurable cancer of the serosal lining that is often caused by exposure to asbestos. Therefore, novel agents for the prevention and treatment of this disease...
5.
Pietrofesa R, Chatterjee S, Kadariya Y, Testa J, Albelda S, Christofidou-Solomidou M
Int J Mol Sci
. 2022 Sep;
23(17).
PMID: 36077483
Although alveolar macrophages play a critical role in malignant transformation of mesothelial cells following asbestos exposure, inflammatory and oxidative processes continue to occur in the mesothelial cells lining the pleura...
6.
Song Y, Baxter S, Dai L, Sanders C, Burkett S, Baugher R, et al.
Cancers (Basel)
. 2022 Jul;
14(13).
PMID: 35804881
Malignant mesothelioma (MMe) is a rare malignancy originating from the linings of the pleural, peritoneal and pericardial cavities. The best-defined risk factor is exposure to carcinogenic mineral fibers (e.g., asbestos)....
7.
Mancuso P, Tricarico R, Bhattacharjee V, Cosentino L, Kadariya Y, Jelinek J, et al.
Oncogene
. 2022 May;
41(23):3300-3301.
PMID: 35505094
No abstract available.
8.
Sementino E, Kadariya Y, Cheung M, Menges C, Tan Y, Kukuyan A, et al.
Mol Cancer Res
. 2022 Jan;
20(5):699-711.
PMID: 35082167
Implications: We provide evidence supporting a role for PAK inhibitors in treating NF2-deficient tumors. NF2-deficient tumors lacking Pak2 eventually adapt by kinome reprogramming, presenting opportunities for combination therapies to bypass...
9.
Cheung M, Kadariya Y, Sementino E, Hall M, Cozzi I, Ascoli V, et al.
Hum Mol Genet
. 2021 May;
30(18):1750-1761.
PMID: 34008015
There is irrefutable evidence that germline BRCA1-associated protein 1 gene (BAP1) mutations contribute to malignant mesothelioma (MM) susceptibility. However, BAP1 mutations are not found in all cases with evidence of...
10.
Kukuyan A, Sementino E, Kadariya Y, Menges C, Cheung M, Tan Y, et al.
Cancer Res
. 2019 Jun;
79(16):4113-4123.
PMID: 31151962
Pleural malignant mesothelioma is a therapy-resistant cancer affecting the serosal lining of the thoracic cavity. Mutations/deletions of , and are the most frequent genetic lesions in human malignant mesothelioma. We...